Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling

Journal of Neurophysiology

Volumn 113, Issue 7, 2015, Pages 2786-2791

  da Silva, Alexandre A ^a   Spradley, Frank T ^a   Granger, Joey P ^a   Hall, John E ^a   do Carmo, Jussara M ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Food intake; Heart rate; Insulin; Leptin; Melanocortin; Streptozotocin

Indexed keywords

GLUCOSE; LEPTIN; MELANOCORTIN 4 RECEPTOR; MC4R PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APPETITE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN FUNCTION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FOOD INTAKE; GENE INACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEART RATE; HYPERGLYCEMIA; HYPERPHAGIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; WEIGHT REDUCTION; ANIMAL; ANOREXIA; BLOOD PRESSURE; BRAIN; DIABETES MELLITUS; DRUG EFFECTS; EATING; KNOCKOUT MOUSE; METABOLISM; MOUSE; WISTAR RAT;

ANIMALS; ANOREXIA; BLOOD PRESSURE; BRAIN; DIABETES MELLITUS; EATING; GLUCOSE; HEART RATE; LEPTIN; MALE; MICE; MICE, KNOCKOUT; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 84982737903     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00911.2014     Document Type: Article

References (36)

1. Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493-505, 2005.
2. Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brainderived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 150: 2646-2653, 2009.
3. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 380: 677, 1996.
4. da Silva AA, do Carmo JM, Dubinion JH, Hall JE. Ganglionic blockade does not impair the chronic CNS-mediated antidiabetic action of leptin in streptozotocin-induced diabetic rats (Abstract). FASEB J 26: 1128.3, 2012.
5. da Silva AA, do Carmo JM, Freeman JN, Tallam LS, Hall JE. A functional melanocortin system is required for the antidiabetic and cardiovascular actions of leptin in diabetic rats. Diabetes 58: 1749-1756, 2009.
6. da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 51: 884-890, 2008.
7. da Silva AA, do Carmo JM, Wang Z, Hall JE. The brain melanocortin system, sympathetic control and obesity hypertension. Physiology (Bethesda) 29: 196-202, 2014.
8. da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43: 1312-1317, 2004.
9. da Silva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. Am J Physiol Regul Integr Comp Physiol 291: R1275-R1282, 2006.
10. do Carmo JM, da Silva AA, Dubinion J, Cai Z, Hall JE. Control of blood pressure, appetite and glucose by leptin in mice lacking leptin receptors in POMC neurons. Hypertension 57: 918-926, 2011.
11. do Carmo JM, da Silva AA, Rushing JS, Pace B, Hall JE. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. Am J Physiol Regul Integr Comp Physiol 305: R359-R368, 2013.
12. do Carmo JM, da Silva AA, Rushing JS, Hall JE. Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 302: R561-R567, 2012.
13. do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in STZ-diabetic rats. Am J Physiol Heart Circ Physiol 295: H1974-H1981, 2008.
14. do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, Hall JE. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor deficient mice. Am J Physiol Regul Integr Comp Physiol 297: R803-R812, 2009.
15. German J, Kim F, Schwartz GJ, Havel PJ, Rhodes CJ, Schwartz MW, Morton GJ. Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 150: 4502-4511, 2009.
16. German JP, Thaler JP, Wisse BE, Shinsuke OI, Sarruf DA, Matsen ME, Fischer JD, Taborsky GJ Jr, Schwartz MW, Morton GJ. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152: 394-404, 2011.
17. Greenfield JR. Melanocortin signaling and the regulation of blood pressure in human obesity. J Neuroendocrinol 23: 186-93, 2011.
18. Greenfield JR, Miller JW, Keogh JM, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O’Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 360: 44-52, 2009.
19. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T. Role of sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats. Diabetes 48: 1706-1712, 1999.
20. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension 30: 619-623, 1997.
21. Hidaka S, Yoshimatsu H, Kondou S, Tsuruta Y, Oka K, Noguchi H, Okamoto K, Sakino H, Teshima Y, Okeda T, Sakata T. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J 16: 509-518, 2002.
22. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377, 1997.
23. Kuo JJ, da Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 41: 768-774, 2003.
24. Li X, Wu X, Camacho R, Schwartz GJ, LeRoith D. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PLos One 6: e17058, 2011.
25. Lin C, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 282: E1084-E1091, 2002.
26. Meek TH, Matsen ME, Damian V, Cubelo A, Chua SC Jr, Morton GJ. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes. Endocrinology 155: 4157-4167, 2014.
27. Nicholson JR, Peter JC, Lecourt AC, Barde YA, Hofbauer KG. Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 19: 974-982, 2007.
28. Rossi J, Balthasar N, Olson D, Scott M, Berglund E, Lee CE, Choi MJ, Lauzon D, Lowell BB, Elmquist JK. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab 13: 195-204, 2011.
29. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
30. Sohn JW, Harris LE, Berglund ED, Liu T, Vong L, Lowell BB, Balthasar N, Williams KW, Elmquist JK. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152: 612-619, 2013.
31. Stepp DW, Osakwee CC, de Chantemele EJ, Mintz JD. Vascular effects of deletion of melanocortin-4 receptors in rats. Physiol Rep 1: e00146, 2013.
32. Tallam LS, da Silva AA, Hall JE. Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension 48: 58-64, 2006.
33. Tallam LS, Stec DE, da Silva AA, Kuo JJ, Hall JE. Melanocortin-4 receptor deficient mice are neither hypertensive nor salt-sensitive despite obesity. Hypertension 46: 326-332, 2005.
34. Tao YX. The melanocortin-4 receptor: physiology, pharmacology and pathophysiology. Endocr Rev 31: 506-543, 2010.
35. Yosten GL, Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 298: R1642-R1647, 2010.
36. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene, and its human homologue. Nature 372: 425-432, 1994.